BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 31127417)

  • 1. Understanding the Role of Preferential Exclusion of Sugars and Polyols from Native State IgG1 Monoclonal Antibodies and its Effect on Aggregation and Reversible Self-Association.
    Sudrik CM; Cloutier T; Mody N; Sathish HA; Trout BL
    Pharm Res; 2019 May; 36(8):109. PubMed ID: 31127417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity.
    Cloutier T; Sudrik C; Mody N; Sathish HA; Trout BL
    Mol Pharm; 2019 Aug; 16(8):3657-3664. PubMed ID: 31276620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential interactions of trehalose, L-arginine.HCl and sodium chloride with therapeutically relevant IgG1 monoclonal antibodies.
    Sudrik C; Cloutier T; Pham P; Samra HS; Trout BL
    MAbs; 2017 Oct; 9(7):1155-1168. PubMed ID: 28758834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of polyol sugars on the stabilization of monoclonal antibodies.
    Nicoud L; Cohrs N; Arosio P; Norrant E; Morbidelli M
    Biophys Chem; 2015 Feb; 197():40-6. PubMed ID: 25645712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of antibody-polyol interactions by static light scattering: implications for physical stability of protein formulations.
    Abbas SA; Sharma VK; Patapoff TW; Kalonia DS
    Int J Pharm; 2013 May; 448(2):382-9. PubMed ID: 23583711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies.
    Thakkar SV; Joshi SB; Jones ME; Sathish HA; Bishop SM; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3062-77. PubMed ID: 22581714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osmolyte Effects on Monoclonal Antibody Stability and Concentration-Dependent Protein Interactions with Water and Common Osmolytes.
    Barnett GV; Razinkov VI; Kerwin BA; Blake S; Qi W; Curtis RA; Roberts CJ
    J Phys Chem B; 2016 Apr; 120(13):3318-30. PubMed ID: 27007711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody.
    Cleland JL; Lam X; Kendrick B; Yang J; Yang TH; Overcashier D; Brooks D; Hsu C; Carpenter JF
    J Pharm Sci; 2001 Mar; 90(3):310-21. PubMed ID: 11170024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometry.
    Manikwar P; Majumdar R; Hickey JM; Thakkar SV; Samra HS; Sathish HA; Bishop SM; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2013 Jul; 102(7):2136-51. PubMed ID: 23620222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Characterization of Antibody-Excipient Interactions for Rational Excipient Selection Using the Site Identification by Ligand Competitive Saturation-Biologics Approach.
    Jo S; Xu A; Curtis JE; Somani S; MacKerell AD
    Mol Pharm; 2020 Nov; 17(11):4323-4333. PubMed ID: 32965126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix?
    Chang L; Shepherd D; Sun J; Ouellette D; Grant KL; Tang XC; Pikal MJ
    J Pharm Sci; 2005 Jul; 94(7):1427-44. PubMed ID: 15920775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of disaccharides alone and in combination, for the improvement of stability and particle properties of spray-freeze dried IgG.
    Daneshmand B; Faghihi H; Amini Pouya M; Aghababaie S; Darabi M; Vatanara A
    Pharm Dev Technol; 2019 Apr; 24(4):439-447. PubMed ID: 30070161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.
    Wen L; Zheng X; Wang X; Lan H; Yin Z
    Pharm Res; 2017 Jul; 34(7):1378-1390. PubMed ID: 28401430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Arginine on the Aggregation of Protein in Freeze-Dried Formulations Containing Sugars and Polyol: 1-Formulation Development.
    Hackl E; Darkwah J; Smith G; Ermolina I
    AAPS PharmSciTech; 2018 Feb; 19(2):896-911. PubMed ID: 29047017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular computations of preferential interactions of proline, arginine.HCl, and NaCl with IgG1 antibodies and their impact on aggregation and viscosity.
    Cloutier TK; Sudrik C; Mody N; Hasige SA; Trout BL
    MAbs; 2020; 12(1):1816312. PubMed ID: 32938318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorbitol crystallization-induced aggregation in frozen mAb formulations.
    Piedmonte DM; Hair A; Baker P; Brych L; Nagapudi K; Lin H; Cao W; Hershenson S; Ratnaswamy G
    J Pharm Sci; 2015 Feb; 104(2):686-97. PubMed ID: 25219372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1.
    Hu Y; Arora J; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):340-352. PubMed ID: 31201906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 2.
    Hu Y; Toth RT; Joshi SB; Esfandiary R; Middaugh CR; Volkin DB; Weis DD
    J Pharm Sci; 2020 Jan; 109(1):353-363. PubMed ID: 31195015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of IgG1 in spray-dried powders for inhalation.
    Schüle S; Schulz-Fademrecht T; Garidel P; Bechtold-Peters K; Frieb W
    Eur J Pharm Biopharm; 2008 Aug; 69(3):793-807. PubMed ID: 18477504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.